Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Next Generation Sequencing (NGS)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02210741
What this trial is testing

Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

Who this might be right for
Graves Disease
National Taiwan University Hospital 200
Not applicableStudy completedNCT01851213
What this trial is testing

FoundationOne™ Test Registry Study

Who this might be right for
CancerNeoplasm MetastasisTumor
Foundation Medicine 510
Not applicableStudy completedNCT03172156
What this trial is testing

CtDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

Who this might be right for
Non-small Cell Lung Cancer Stage I
Sun Yat-sen University 100
Not applicableLooking for participantsNCT05257551
What this trial is testing

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Who this might be right for
Small Cell Lung Cancer
Tempus AI 200
Not applicableUnknownNCT05058937
What this trial is testing

Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

Who this might be right for
Solid TumorMetastatic Cancer
The Belgian Society of Medical Oncology 936
Not applicableNot Yet RecruitingNCT06763302
What this trial is testing

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Who this might be right for
B Cell Precursor Acute Lymphoblastic LeukemiaPediatricMinimal Residual Disease+1 more
The Children's Hospital of Zhejiang University School of Medicine 1,220
Not applicableStudy completedNCT02268786
What this trial is testing

Single Embryo TrAnsfeR of Euploid Embryo

Who this might be right for
InfertilityAneuploidy
Illumina, Inc. 661
Not applicableUnknownNCT03228368
What this trial is testing

The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
First Affiliated Hospital of Zhejiang University 10
Not applicableUnknownNCT04641676
What this trial is testing

Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

Who this might be right for
Metastatic CancerLocal Tumor Invasion
The Belgian Society of Medical Oncology 1,000
Not applicableStudy completedNCT05973032
What this trial is testing

MRD Detection by NGS in Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 430
Testing effectiveness (Phase 2)Ended earlyNCT04265534
What this trial is testing

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 40
Testing effectiveness (Phase 2)UnknownNCT04059081
What this trial is testing

A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment

Who this might be right for
Chronic Lymphocytic Leukemia
Deok-Hwan Yang 31
Not applicableWithdrawnNCT05292443
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Who this might be right for
Primary Liver CancerHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma+1 more
Geneplus-Beijing Co. Ltd.
Not applicableUnknownNCT03002350
What this trial is testing

Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)

Who this might be right for
RecurrenceMetastasisDeath
Chang Gung Memorial Hospital 40
Not applicableStudy completedNCT04364828
What this trial is testing

NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression

Who this might be right for
COVID-19
University Hospital Tuebingen 1,000
Not applicableLooking for participantsNCT04731857
What this trial is testing

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

Who this might be right for
Rare DiseasesGenetic Predisposition
University Hospital Tuebingen 12,000
Not applicableStudy completedNCT02420405
What this trial is testing

Mutation Detection of EBUS-TBNA Specimens Using NGS

Who this might be right for
Lung Cancer
Jiayuan Sun 78
Not applicableUnknownNCT02588638
What this trial is testing

Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases

Who this might be right for
Movement DisorderCognitive Decline
University Hospital Tuebingen 100
Not applicableLooking for participantsNCT05701787
What this trial is testing

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

Who this might be right for
NSCLCNSCLC Stage IVNSCLC, Recurrent
Shanghai Chest Hospital 500
Not applicableUnknownNCT04346043
What this trial is testing

To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database

Who this might be right for
Coronavirus Disease (COVID-19)
Ain Shams University 100
Next Page